English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community
Press release submission | Nov 5, 2021

Spinal Cord Stimulator (SCS) Changes Patients' Lives Patient Pain Relief with Treatment

Press release submission | Nov 4, 2021

US Food and Drug Administration Declines Emergency Use Authorization for ZYESAMI® (aviptadil) for Patients with Critical COVID-19 with Respiratory Failure

Press release submission | Nov 4, 2021

Medtronic study shows patients with high blood pressure are interested in an interventional procedure treatment option

Press release submission | Nov 4, 2021

Remote Patient Monitoring Platform 100Plus Powered by Artificial Intelligence Health Assistant Ava Leads to Improved Health Metrics for Senior Adult Patients

Press release submission | Oct 31, 2021

HOPSTEM completed 40 million USD series B financing, to develop safe, effective and affordable iPSC cell therapies for global patients

Press release submission | Oct 30, 2021

Akebia Announces Otsuka's Submission of Initial Marketing Authorization Application to the European Medicines Agency for Vadadustat for the Treatment of Patients with Anemia due to Chronic Kidney Disease

Press release submission | Oct 29, 2021

Banty's Dr. Richard Tytus Explains How to Have Successful Virtual Medicine Appointments with Patients

Press release submission | Oct 29, 2021

HUYABIO Announces FDA Clearance to Initiate a Phase 1 Trial of SHP2 Inhibitor in Patients with KRAS and EGFR Mutated Tumors

Trending

+ Pharmaceuticals
Patient Daily | Jun 18, 2025

ENT specialist on acid reflux: ‘You actually have a structural issue that may predispose you to sinusitis’

+ Pharmaceuticals
Patient Daily | Jun 16, 2025

American Consumer Institute questions hospital use of 340B Drug Pricing Program

+ Pharmaceuticals
Patient Daily | Jun 13, 2025

Data scientist: ‘340B sales growth was 115.5% higher than the growth of non-340B sales in 2023’

+ Pharmaceuticals
Patient Daily | Jun 19, 2025

Patients Come First spokesperson on 340B reform: ‘Americans deserve a system that prioritizes patients first, not pharmacy middlemen’

  • « First
  • «
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2025 Patient Daily